KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Sales (2016 - 2025)

Eli Lilly (LLY) has disclosed Return on Sales for 16 consecutive years, with 0.34% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 2.0% year-over-year to 0.34%, compared with a TTM value of 0.32% through Dec 2025, up 8.0%, and an annual FY2025 reading of 0.32%, up 8.0% over the prior year.
  • Return on Sales was 0.34% for Q4 2025 at Eli Lilly, up from 0.32% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.36% in Q2 2025 and bottomed at 0.01% in Q3 2023.
  • Average Return on Sales over 5 years is 0.22%, with a median of 0.22% recorded in 2021.
  • The sharpest move saw Return on Sales dropped -22bps in 2023, then increased 23bps in 2025.
  • Year by year, Return on Sales stood at 0.22% in 2021, then grew by 23bps to 0.27% in 2022, then decreased by -12bps to 0.23% in 2023, then skyrocketed by 39bps to 0.33% in 2024, then increased by 6bps to 0.34% in 2025.
  • Business Quant data shows Return on Sales for LLY at 0.34% in Q4 2025, 0.32% in Q3 2025, and 0.36% in Q2 2025.